18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Lipid accumulation in human breast cancer cells injured by iron depletors

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Current insights into the effects of iron deficiency in tumour cells are not commensurate with the importance of iron in cell metabolism. Studies have predominantly focused on the effects of oxygen or glucose scarcity in tumour cells, while attributing insufficient emphasis to the inadequate supply of iron in hypoxic regions. Cellular responses to iron deficiency and hypoxia are interlinked and may strongly affect tumour metabolism.

          Methods

          We examined the morphological, proteomic, and metabolic effects induced by two iron chelators—deferoxamine (DFO) and di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT)—on MDA-MB-231 and MDA-MB-157 breast cancer cells.

          Results

          These chelators induced a cytoplasmic massive vacuolation and accumulation of lipid droplets (LDs), eventually followed by implosive, non-autophagic, and non-apoptotic death similar to methuosis. Vacuoles and LDs are generated by expansion of the endoplasmic reticulum (ER) based on extracellular fluid import, which includes unsaturated fatty acids that accumulate in LDs. Typical physiological phenomena associated with hypoxia are observed, such as inhibition of translation, mitochondrial dysfunction, and metabolic remodelling. These survival-oriented changes are associated with a greater expression of epithelial/mesenchymal transcription markers.

          Conclusions

          Iron starvation induces a hypoxia-like program able to scavenge nutrients from the extracellular environment, and cells assume a hypertrophic phenotype. Such survival strategy is accompanied by the ER-dependent massive cytoplasmic vacuolization, mitochondrial dysfunctions, and LD accumulation and then evolves into cell death. LDs containing a greater proportion of unsaturated lipids are released as a consequence of cell death. The consequence of the disruption of iron metabolism in tumour tissue and the effects of LDs on intercellular communication, cancer–inflammation axis, and immunity remain to be explored. Considering the potential benefits, these are crucial subjects for future mechanistic and clinical studies.

          Electronic supplementary material

          The online version of this article (10.1186/s13046-018-0737-z) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references60

          • Record: found
          • Abstract: found
          • Article: not found

          Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis.

          The majority of eukaryotic cells synthesize neutral lipids and package them into cytosolic lipid droplets. In vertebrates, triacylglycerol-rich lipid droplets of adipocytes provide a major energy storage depot for the body, whereas cholesteryl ester-rich droplets of many other cells provide building materials for local membrane synthesis and repair. These lipid droplets are coated with one or more of five members of the perilipin family of proteins: adipophilin, TIP47, OXPAT/MLDP, S3-12, and perilipin. Members of this family share varying levels of sequence similarity, lipid droplet association, and functions in stabilizing lipid droplets. The most highly studied member of the family, perilipin, is the most abundant protein on the surfaces of adipocyte lipid droplets, and the major substrate for cAMP-dependent protein kinase [protein kinase A (PKA)] in lipolytically stimulated adipocytes. Perilipin serves important functions in the regulation of basal and hormonally stimulated lipolysis. Under basal conditions, perilipin restricts the access of cytosolic lipases to lipid droplets and thus promotes triacylglycerol storage. In times of energy deficit, perilipin is phosphorylated by PKA and facilitates maximal lipolysis by hormone-sensitive lipase and adipose triglyceride lipase. A model is discussed whereby perilipin serves as a dynamic scaffold to coordinate the access of enzymes to the lipid droplet in a manner that is responsive to the metabolic status of the adipocyte.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment.

            Solid tumors typically develop hostile microenvironments characterized by irregular vascularization and poor oxygen (O2) and nutrient supply. Whereas normal cells modulate anabolic and catabolic pathways in response to changes in nutrient availability, cancer cells exhibit unregulated growth even under nutrient scarcity. Recent studies have demonstrated that constitutive activation of growth-promoting pathways results in dependence on unsaturated fatty acids for survival under O2 deprivation. In cancer cells, this dependence represents a critical metabolic vulnerability that could be exploited therapeutically. Here we review how this dependence on unsaturated lipids is affected by the microenvironmental conditions faced by cancer cells. Copyright © 2014 Elsevier Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids.

              One of the most important metabolic hallmarks of cancer cells is enhanced lipogenesis. Depending on the tumor type, tumor cells synthesize up to 95% of saturated and mono-unsaturated fatty acids (FA) de novo in spite of sufficient dietary lipid supply. This lipogenic conversion starts early when cells become cancerous and further expands as the tumor cells become more malignant. It is suggested that activation of FA synthesis is required for carcinogenesis and for tumor cell survival. These observations suggest that the enzymes involved in FA synthesis would be rational therapeutic targets for cancer treatment. However, several recent reports have shown that the anti-tumor effects, following inhibition of endogenous FA synthesis in cancer cell lines may be obviated by adding exogenous FAs. Additionally, high intake of dietary fat is reported to be a potential risk factor for development and poor prognosis for certain cancers. Recently it was reported that breast and liposarcoma tumors are equipped for both de novo fatty acid synthesis pathway as well as LPL-mediated extracellular lipolysis. These observations indicate that lipolytically acquired FAs may provide an additional source of FAs for cancer. This review focuses on our current understanding of lipogenic and lipolytic pathways in cancer cell progression. Copyright © 2013 Elsevier Ltd. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                maida.debortoli@gmail.com
                eletav@hotmail.com
                elisa.maffioli@unimi.it
                patrizia.casalini@istitutotumori.mi.it
                francesco.crisafi89@gmail.com
                nasavikas@gmail.com
                Claudio.Caccia@istituto-besta.it
                dario.polli@polimi.it
                gabriella.tedeschi@unimi.it
                Italia.bongarzone@istitutotumori.mi.it
                Journal
                J Exp Clin Cancer Res
                J. Exp. Clin. Cancer Res
                Journal of Experimental & Clinical Cancer Research : CR
                BioMed Central (London )
                0392-9078
                1756-9966
                3 April 2018
                3 April 2018
                2018
                : 37
                : 75
                Affiliations
                [1 ]ISNI 0000 0001 0807 2568, GRID grid.417893.0, Fondazione IRCCS Istituto Nazionale dei Tumori, ; via G. Amadeo 42, Milan, 20133 Italy
                [2 ]ISNI 0000 0004 1757 2822, GRID grid.4708.b, Dipartimento di Medicina Veterinaria (DiMeVet), , University of Milan, ; Milan, I-20133 Italy
                [3 ]ISNI 0000 0001 0807 2568, GRID grid.417893.0, Molecular Targeting Unit, , Fondazione IRCCS Istituto Nazionale dei Tumori, ; Via Amadeo 42, 20133 Milan, Italy
                [4 ]ISNI 0000 0004 1937 0327, GRID grid.4643.5, IFN-CNR, Dipartimento di Fisica, , Politecnico di Milano, ; Piazza Leonardo da Vinci 32, 20133 Milan, Italy
                [5 ]Laboratory of Clinical Pathology and Medical Genetics, Fondazione IRCCS ‘Carlo Besta’ Istituto Neurologico, Via Amadeo 42, 20133 Milan, Italy
                [6 ]ISNI 0000 0004 1764 2907, GRID grid.25786.3e, Center for Nano Science and Technology at Polimi, , Istituto Italiano di Tecnologia, ; 20133 Milan, Italy
                [7 ]GRID grid.434010.2, Fondazione Filarete, ; I-20139 Milan, Italy
                Author information
                http://orcid.org/0000-0003-2530-9170
                Article
                737
                10.1186/s13046-018-0737-z
                5883539
                29615075
                43d38398-4852-4493-86ee-5a387c177e3e
                © The Author(s). 2018

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 9 November 2017
                : 15 March 2018
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100005010, Associazione Italiana per la Ricerca sul Cancro;
                Award ID: IG_13208
                Award Recipient :
                Funded by: Italian Ministry of Public Health
                Categories
                Research
                Custom metadata
                © The Author(s) 2018

                Oncology & Radiotherapy
                breast cancer,cytoplasm vacuolation,endoplasmic reticulum stress,iron chelation,lipid droplets,macropinocytosis,mitochondria dysfunctions,methuotic cell death,hypoxia,raman spectroscopy

                Comments

                Comment on this article